Corporate earnings are off to a hot start, with a slew of Wall Street banks beating analysts’ expectations. Shares of JPMorgan and Wells Fargo and closed higher Friday after the banks surpassed quarterly estimates. Elsewhere, UnitedHealth Group , a heavyweight in the Dow Jones Industrial Average, gained 2.6% after beating analysts’ estimates for earnings and revenue. A number of stocks reporting in the week ahead have a great track record of topping earnings estimates and rallying, according to Bespoke Investment Group data. We looked at stocks that meet the following criteria: Historical earnings per share beat rate of 70% or more The stock historically rises on average by at least 1% after results are out Here’s the list: Regional bank Citizens Financial has historically beaten Wall Street earnings per share estimates 71% of the time, which has lifted the stock 1.69% on average after posting results, according to Bespoke. Citizens stock has slipped more than 34% in 2023. Last month, Goldman Sachs said the firm sees “meaningful upside” for the stock if it can execute on balance sheet optimization, as well as its efforts to control costs. Citizens Financial will report third-quarter results on Oct. 18 before the opening bell. CFG YTD mountain Citizens Financial stock. Western Alliance stock, meanwhile, has slipped more than 25% in 2023. The banking crisis in March rocked shares of regional institutions, and Western Alliance saw its stock tumble 52% that month. The bank has since reiterated that deposits remain stable, and analysts have been upbeat on the name. Western Alliance has surpassed Wall Street EPS estimates 87% of the time historically, which has pushed shares 2.2% higher after the report, per Bespoke. Western Alliance will report third-quarter results on Oct. 19 after the closing bell. WAL YTD mountain Western Alliance stock. Lam Research has beaten EPS estimates a staggering 92% of the time historically, while shares have gained 1.3% after the report, Bespoke found. Shares of the semiconductor company have added nearly 54% from the start of the year, and Lam Research will report results after the close on Oct. 18 . LRCX YTD mountain Lam Research stock. Needham upgraded shares to buy from hold on Friday. “LRCX looks to be an outperformer in 2024-2025,” wrote analyst Charles Shi. “We believe consensus estimates will move higher, and expect LRCX shares to outperform.” -CNBC’s Michael Bloom contributed reporting.